News
Q4 2024 Earnings Conference Call May 20, 2025 10:00 AM ETCompany ParticipantsCassio Bobsin - Founder and CEOShay Chor - CFO ...
AstraZeneca’s biologics division MedImmune is to spin out a new standalone biotech to develop six early-stage inflammation and autoimmunity programmes. To be known as Viela Bio, the spin-out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback